Reena Jayani

1.1k total citations · 1 hit paper
39 papers, 562 citations indexed

About

Reena Jayani is a scholar working on Oncology, Hematology and Geriatrics and Gerontology. According to data from OpenAlex, Reena Jayani has authored 39 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 16 papers in Hematology and 10 papers in Geriatrics and Gerontology. Recurrent topics in Reena Jayani's work include Hematopoietic Stem Cell Transplantation (11 papers), CAR-T cell therapy research (8 papers) and Frailty in Older Adults (8 papers). Reena Jayani is often cited by papers focused on Hematopoietic Stem Cell Transplantation (11 papers), CAR-T cell therapy research (8 papers) and Frailty in Older Adults (8 papers). Reena Jayani collaborates with scholars based in United States, Mexico and Belgium. Reena Jayani's co-authors include Arti Hurria, Vani Katheria, Can‐Lan Sun, William Dale, Enrique Soto‐Pérez‐de‐Celis, Simone Fernandes Dos Santos Hughes, Joseph Chao, Cynthia M. Kelly, Elsa Roberts and Vincent Chung and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Reena Jayani

31 papers receiving 561 citations

Hit Papers

Geriatric Assessment–Driven Intervention (GAIN) on Chemot... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reena Jayani United States 10 272 226 161 134 103 39 562
Mustafa Al‐Obaidi United States 14 266 1.0× 259 1.1× 240 1.5× 86 0.6× 49 0.5× 42 578
J.M. Jonker Netherlands 6 334 1.2× 187 0.8× 236 1.5× 52 0.4× 25 0.2× 6 609
Yat Ming Lau China 7 118 0.4× 142 0.6× 70 0.4× 52 0.4× 19 0.2× 13 350
J.P. Jacquin France 8 211 0.8× 215 1.0× 209 1.3× 54 0.4× 12 0.1× 12 512
Capucine Baldini France 10 93 0.3× 184 0.8× 41 0.3× 30 0.2× 18 0.2× 19 336
Jane Jijun Liu United States 12 40 0.1× 172 0.8× 75 0.5× 89 0.7× 67 0.7× 23 405
M.J. Molina-Garrido Spain 11 124 0.5× 151 0.7× 94 0.6× 30 0.2× 9 0.1× 32 313
Alysia Bosworth United States 9 50 0.2× 182 0.8× 39 0.2× 91 0.7× 179 1.7× 45 429
Nina Rosa Neuendorff Germany 10 66 0.2× 80 0.4× 46 0.3× 64 0.5× 128 1.2× 37 296
Oliver Higuera Spain 13 61 0.2× 305 1.3× 40 0.2× 54 0.4× 16 0.2× 40 480

Countries citing papers authored by Reena Jayani

Since Specialization
Citations

This map shows the geographic impact of Reena Jayani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reena Jayani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reena Jayani more than expected).

Fields of papers citing papers by Reena Jayani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reena Jayani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reena Jayani. The network helps show where Reena Jayani may publish in the future.

Co-authorship network of co-authors of Reena Jayani

This figure shows the co-authorship network connecting the top 25 collaborators of Reena Jayani. A scholar is included among the top collaborators of Reena Jayani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reena Jayani. Reena Jayani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jayani, Reena, Andrew Jallouk, James H. Jerkins, et al.. (2025). Impact of Granulocyte Colony Stimulating Factor Use Following CD-19 Chimeric Antigen Receptor T-Cell Therapy. Transplantation and Cellular Therapy. 32(1). 48–58. 1 indexed citations
2.
Banerjee, Rahul, Hermioni L. Amonoo, Anna Barata, et al.. (2025). Assessing Quality of Life and Symptoms in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCT. Transplantation and Cellular Therapy. 31(10). 774–788.
3.
Dholaria, Bhagirathbhai, Shakthi Bhaskar, Reena Jayani, et al.. (2025). Feasibility of axicabtagene ciloleucel in the outpatient setting: primary analysis of prospective trial. Bone Marrow Transplantation. 60(6). 769–772.
4.
Johnson, G. Allan, Shakthi Bhaskar, Bhagirathbhai Dholaria, et al.. (2025). The Safety of Intrathecal Therapy in the Treatment of Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS). Transplantation and Cellular Therapy. 31(2). S239–S239.
5.
Dholaria, Bhagirathbhai, Adetola A. Kassim, Reena Jayani, et al.. (2024). Flat dose intravenous immunoglobulin (IVIG) for primary infection prophylaxis after CAR-T for B-cell non-Hodgkin lymphoma (B-NHL).. Journal of Clinical Oncology. 42(16_suppl). e19004–e19004. 1 indexed citations
6.
Park, Silvia, Rahul Shah, Carlos Prieto‐Granada, et al.. (2024). GVHD like skin eruption post-autologous stem cell transplantation. Bone Marrow Transplantation. 59(6). 900–903.
7.
Shah, Rahul, Danielle Murphy, James H. Jerkins, et al.. (2024). Multidisciplinary Management of Morbidities Associated with Chronic Graft-Versus-Host Disease. PubMed. 6(4). 74–88. 3 indexed citations
8.
Gatwood, Katie S., Reena Jayani, Andrew Jallouk, et al.. (2024). Evaluating Antibiotic De-escalation for Autologous Stem Cell Transplant Patients With Febrile Neutropenia in a Real-World Clinical Setting. Transplantation and Cellular Therapy. 30(10). 1031.e1–1031.e9. 1 indexed citations
9.
Gilmore, R.M., Adetola A. Kassim, Salyka Sengsayadeth, et al.. (2024). Efficacy and safety of outpatient fludarabine, cyclophosphamide, and rituximab based allogeneic hematopoietic cell transplantation in adults with severe aplastic anemia. Bone Marrow Transplantation. 59(9). 1275–1279.
10.
Wall, Sarah, Rebecca L. Olin, Vijaya Raj Bhatt, et al.. (2023). The Transplantation Ecosystem: A New Concept to Improve Access and Outcomes for Older Allogeneic Hematopoietic Cell Transplantation Patients. Transplantation and Cellular Therapy. 29(10). 632.e1–632.e10. 8 indexed citations
11.
Chen, Heidi, Deva Sharma, Michael Byrne, et al.. (2022). Reduction in the Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Transplantation. Transplantation and Cellular Therapy. 28(5). 277.e1–277.e6. 3 indexed citations
12.
Hoogland, Aasha I., Anna Barata, Jennifer M. Logue, et al.. (2022). Change in Neurocognitive Performance Among Patients with Non-Hodgkin Lymphoma in the First Year after Chimeric Antigen Receptor T Cell Therapy. Transplantation and Cellular Therapy. 28(6). 305.e1–305.e9. 29 indexed citations
13.
Barata, Anna, Aasha I. Hoogland, Anuhya Kommalapati, et al.. (2022). Change in Patients’ Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma. Transplantation and Cellular Therapy. 28(7). 401.e1–401.e7. 26 indexed citations
14.
Barata, Anna, Aasha I. Hoogland, Kelly A. Hyland, et al.. (2021). Quality of life in caregivers of patients receiving chimeric antigen receptor T‐cell therapy. Psycho-Oncology. 30(8). 1294–1301. 18 indexed citations
15.
Abedin, Sameem, Mark A. Schroeder, Rizwan Romee, et al.. (2021). Ruxolitinib resistance or intolerance in steroid‐refractory acute graft‐versus‐host disease — a real‐world outcomes analysis. British Journal of Haematology. 195(3). 429–432. 10 indexed citations
16.
Jayani, Reena, Joseph Pidala, Heather Jim, et al.. (2021). Association of Patient-Reported Physical Activity on Allogeneic Hematopoietic Cell Transplant Outcomes. SHILAP Revista de lepidopterología. 3(1). 34–34. 4 indexed citations
17.
Jayani, Reena, Allison Magnuson, Can‐Lan Sun, et al.. (2019). Association between a cognitive screening test and severe chemotherapy toxicity in older adults with cancer. Journal of Geriatric Oncology. 11(2). 284–289. 14 indexed citations
18.
Jayani, Reena & Arti Hurria. (2012). Caregivers of Older Adults With Cancer. Seminars in Oncology Nursing. 28(4). 221–225. 41 indexed citations
19.
Maggiore, Ronald J., Molly Hardt, William P. Tew, et al.. (2011). Polypharmacy, potentially inappropriate medications, and chemotherapy-related adverse events among older adults with cancer.. Journal of Clinical Oncology. 29(15_suppl). e19501–e19501. 6 indexed citations
20.
Gajra, Ajeet, Molly Hardt, William P. Tew, et al.. (2011). Primary dose reduction (PDR) of chemotherapy (chemo) in patients (Pts) older than age 65 with advanced cancer (Ca) and toxicity outcomes.. Journal of Clinical Oncology. 29(15_suppl). 9037–9037. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026